Collette Health Appoints Christine Gall as Chief Nursing Officer

Christine Gall

Collette Health, a leading provider of virtual patient observation solutions, is pleased to announce the appointment of healthcare visionary Christine Gall DrPH, MS, BSN, as chief nursing officer. In this role, she will oversee all clinical operations and innovation initiatives to further enhance Collette Health’s commitment to helping hospitals integrate virtual patient safety solutions to prevent falls and adverse events and improve patient outcomes.

Experience

Christine Gall brings three decades of experience and a wealth of knowledge in Patient Safety and Engagement, Quality, and Public Health Leadership. Throughout her career, she has leveraged her clinical and leadership expertise to develop new services and programs that address gaps in access and service delivery for at risk and vulnerable patient populations. Gall’s passion for improving healthcare quality, safety, and outcomes has enabled her to sharpen her leadership expertise in a variety of roles and environments spanning the continuum of care and in dozens of care delivery settings.

“I’m thrilled to be joining Collette Health at such a pivotal time as we see the role of clinicians evolve and new technology transform the healthcare industry,” said Gall. “I am eager to join a team that’s driving positive patient outcomes, improving clinical workflows, and helping to reshape the healthcare landscape as hospitals face major challenges that are driving novel care delivery strategies. I look forward to ensuring clinicians have the resources and support needed to thrive in their professional practice and to provide the highest level of care to their patients.”

Educational Background

Gall received her Doctoral Degree in Public Health Leadership (DrPH), from the University of Illinois, Chicago, her Master of Science Degree in Healthcare Management (MS) from the University of Wisconsin-Milwaukee School of Business Administration, and a Bachelor of Nursing Degree (BSN), from the University of Wisconsin-Milwaukee School of Nursing.

Throughout her career, Gall has focused on addressing emerging industry problems and expanding programs to identify gaps and meet the evolving needs in the healthcare sector. She is recognized for her authentic and results-oriented leadership. In her new role, she will collaborate with Collette Health’s product and clinician-led teams to apply human-centered AI to bring new use cases to life.

Holly Miller, president of Collette Health

“Christine’s passion for improving healthcare, coupled with her mission-driven focus on quality and safety, will greatly benefit our team and patients. Her extensive clinical expertise and diverse background makes her an invaluable asset. With her guidance, we’ll continue driving innovation and incorporating crucial clinician feedback for success.”

Collette Health, now rated in Best in KLAS in the virtual sitting and nursing category, remains committed to driving innovation with its virtual patient observation solutions that include persistent two-way video and audio, a 12:1 patient-to-observer ratio, and on-staff virtual observers.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.